<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TAN</journal-id>
<journal-id journal-id-type="hwp">sptan</journal-id>
<journal-title>Therapeutic Advances in Neurological Disorders</journal-title>
<issn pub-type="ppub">1756-2856</issn>
<issn pub-type="epub">1756-2864</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1756285612443300</article-id>
<article-id pub-id-type="publisher-id">10.1177_1756285612443300</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neurostimulation for chronic cluster headache</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wolter</surname><given-names>Tilman</given-names></name>
</contrib>
<aff id="aff1-1756285612443300">Interdisciplinary Pain Centre, University Hospital Freiburg, Breisacherstrasse 64, 79106 Freiburg, Germany</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kaube</surname><given-names>Holger</given-names></name>
</contrib>
<aff id="aff2-1756285612443300">Interdisciplinary Pain Centre, University Hospital Freiburg, Freiburg and Neurology and Headache Centre, Münchner Freiheit, München, Germany</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1756285612443300"><email>tilman.wolter@uniklinik-freiburg.de</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>5</volume>
<issue>3</issue>
<fpage>175</fpage>
<lpage>180</lpage>
<permissions>
<copyright-statement>© The Author(s), 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Neurostimulation techniques for the treatment of primary headache syndromes, particularly of chronic cluster headache, have received much interest in recent years. Occipital nerve stimulation (ONS) has yielded favourable clinical results and, despite the limited numbers of published cases, is becoming a routine treatment for refractory chronic cluster headache in specialized centres. Meanwhile, other promising techniques such as spinal cord stimulation (SCS) or sphenopalate ganglion stimulation have emerged. In this article the current state of clinical research for neurostimulation techniques for chronic cluster headache is reviewed.</p>
</abstract>
<kwd-group>
<kwd>chronic cluster headache</kwd>
<kwd>neurostimulation</kwd>
<kwd>occipital nerve stimulation</kwd>
<kwd>spinal cord stimulation</kwd>
<kwd>sphenopalate ganglion</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1756285612443300">
<title>Cluster headache: definition, clinical characteristics and standard therapy</title>
<p>Cluster headache (CH) is an extremely severe and debilitating trigemino-autonomic primary headache syndrome. Clinically CH is characterized by attacks of severe pain localized orbitally, supraorbitally or temporally, lasting for 15–180 minutes and occurring from once every other day to eight times daily. The attacks are associated with one or more of the following symptoms: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, forehead and facial sweating, miosis, ptosis and eyelid oedema [<xref ref-type="bibr" rid="bibr40-1756285612443300">Silberstein <italic>et al</italic>. 2005</xref>]. Attacks occur in series (so-called cluster periods or bouts) that are usually separated by remission periods lasting for months or years. In chronic cluster headache (CCH) substantial remission periods are missing. Cluster headache has a 1-year prevalence of about 0.1% [<xref ref-type="bibr" rid="bibr41-1756285612443300">Sjaastad and Bakketeig, 2003</xref>] and about 10% of this group have chronic cluster headache [<xref ref-type="bibr" rid="bibr22-1756285612443300">Lance and Goadsby, 2005</xref>].</p>
<p>Usually treatment is based on drug therapy. Agents used for acute therapy are inhalation of high-flow oxygen, sumatriptan subcutaneous injection and zolmitriptan nasal spray. For transitional or short-term prophylaxis, corticosteroids and ergotamine derivatives are used. The cornerstone of maintenance prophylaxis is verapamil, but lithium and methysergide may also be used. Some patients respond to melatonin and topiramate [<xref ref-type="bibr" rid="bibr7-1756285612443300">Dodick and Capobianco, 2001</xref>].</p>
<p>In addition, under optimal medical therapy a number of patients do not experience sufficient pain relief [<xref ref-type="bibr" rid="bibr40-1756285612443300">Silberstein <italic>et al</italic>. 2005</xref>].</p>
<p>Recently, guidelines for the definition of therapy refractory CCH have been proposed [<xref ref-type="bibr" rid="bibr14-1756285612443300">Goadsby <italic>et al</italic>. 2006</xref>], but the exact proportion of these patients is still unknown. However, the number of published lesional and surgical approaches for CCH points towards the considerable size of the problem.</p>
</sec>
<sec id="section2-1756285612443300">
<title>Lesional treatments</title>
<p>A variety of lesional treatments such as glycerol injection [<xref ref-type="bibr" rid="bibr10-1756285612443300">Ekbom <italic>et al</italic>. 1987</xref>], radiofrequency lesioning [<xref ref-type="bibr" rid="bibr45-1756285612443300">Sweet, 1988</xref>; <xref ref-type="bibr" rid="bibr30-1756285612443300">Mathew and Hurt, 1988</xref>] or gamma knife lesioning of the trigeminal nerve [<xref ref-type="bibr" rid="bibr9-1756285612443300">Donnet <italic>et al</italic>. 2005</xref>, <xref ref-type="bibr" rid="bibr8-1756285612443300">2006</xref>; <xref ref-type="bibr" rid="bibr33-1756285612443300">McClelland <italic>et al</italic>. 2006</xref>, <xref ref-type="bibr" rid="bibr32-1756285612443300">2007</xref>], trigeminal tractotomy [<xref ref-type="bibr" rid="bibr15-1756285612443300">Green, 2003</xref>], trigeminal sensory nerve section [<xref ref-type="bibr" rid="bibr17-1756285612443300">Jarrar <italic>et al</italic>. 2003</xref>; <xref ref-type="bibr" rid="bibr20-1756285612443300">Kirkpatrick <italic>et al</italic>. 1993</xref>], surgical section [<xref ref-type="bibr" rid="bibr36-1756285612443300">Rowed, 1990</xref>] or radiofrequency [<xref ref-type="bibr" rid="bibr45-1756285612443300">Sweet, 1988</xref>] of the nervus intermedius, combinations of nerve sections [<xref ref-type="bibr" rid="bibr34-1756285612443300">Morgenlander and Wilkins, 1990</xref>], decompression of the facial nerve [<xref ref-type="bibr" rid="bibr43-1756285612443300">Solomon and Apfelbaum, 1986</xref>] and endoscopic block [<xref ref-type="bibr" rid="bibr11-1756285612443300">Felisati <italic>et al</italic>. 2006</xref>], radiofrequency treatment [<xref ref-type="bibr" rid="bibr37-1756285612443300">Sanders and Zuurmond, 1997</xref>] or gamma knife lesioning [<xref ref-type="bibr" rid="bibr21-1756285612443300">Lad <italic>et al</italic>. 2007</xref>] of the sphenopalatine ganglion have been proposed.</p>
<p>In a study of microvascular decompression of the trigeminal nerve, alone or in combination with section and/or microvascular decompression of the nervus intermedius, the short-term success rate (defined as 50% relief or greater) was 73% but dropped to 46% in long-term follow up. Initially, half of the patients had a relief of more than 90%.</p>
<p>Risks associated with these surgical procedures include death, permanent neurological deficits, corneal anaesthesia and visual loss. Some of these procedures require a craniotomy. Also, a switch of the CCH to other side in the further course is possible.</p>
</sec>
<sec id="section3-1756285612443300">
<title>Deep brain stimulation</title>
<p>The results of posteromedial hypothalamotomy [<xref ref-type="bibr" rid="bibr38-1756285612443300">Sano <italic>et al</italic>. 1970</xref>] and the identification of a hypothalamic activation during cluster attacks [<xref ref-type="bibr" rid="bibr31-1756285612443300">May <italic>et al</italic>. 1998</xref>; <xref ref-type="bibr" rid="bibr44-1756285612443300">Sprenger <italic>et al</italic>. 2004</xref>] led to the use of deep brain stimulation (DBS) for refractory CCH. A first series of 16 patients showed excellent results with 13 patients pain free or nearly pain free and three patients improved [<xref ref-type="bibr" rid="bibr13-1756285612443300">Franzini <italic>et al</italic>. 2003</xref>; <xref ref-type="bibr" rid="bibr23-1756285612443300">Leone, 2006</xref>]. Later studies followed consensus criteria for patient selection [<xref ref-type="bibr" rid="bibr24-1756285612443300">Leone <italic>et al</italic>. 2004</xref>]. In 2008 a review summarized the results of hypothalamic DBS in 38 refractory CCH patients. With a follow up of between 1 and 4 years, 23 patients (61%) were pain free or almost pain free [<xref ref-type="bibr" rid="bibr25-1756285612443300">Leone <italic>et al</italic>. 2008</xref>].</p>
<p>Schoenen and colleagues reported a fatal haemorrhage following DBS implantation due to a previously unnoted cerebral aneurysm. Moreover, in their series of six patients, in another patient the procedure had to be stopped due to panic attacks with autonomic disturbances [<xref ref-type="bibr" rid="bibr39-1756285612443300">Schoenen <italic>et al</italic>. 2005</xref>].</p>
<p>In DBS pain relief can emerge with a delay of up to 3 months. In a prospective, randomized crossover study of 11 patients receiving DBS electrodes, no difference between active and sham stimulation was observed during the blinded crossover phase, however in the open phase six of 11 patients responded to stimulation (decrease in weekly attack frequency of &gt;50%) [<xref ref-type="bibr" rid="bibr12-1756285612443300">Fontaine <italic>et al</italic>. 2010</xref>].</p>
<p>Recently it has been questioned whether stereotactic intervention in these disorders has been targeted at the appropriate locus, and whether this may account for the approximately 40% of patients with a poor response to DBS [<xref ref-type="bibr" rid="bibr29-1756285612443300">Matharu and Zrinzo, 2011</xref>], since the target data for DBS are derived from positron emission tomography (PET) studies with limited spatial resolution and functional magnetic resonance imaging (fMRI) data which have a better spatial resolution hint at a locus of activation antero-superior to that derived from PET studies [<xref ref-type="bibr" rid="bibr28-1756285612443300">Matharu and Zrinzo, 2010</xref>].</p>
</sec>
<sec id="section4-1756285612443300">
<title>Occipital nerve stimulation</title>
<p>Occipital nerve stimulation (ONS) had been proposed as a treatment for refractory migraine [<xref ref-type="bibr" rid="bibr27-1756285612443300">Matharu <italic>et al</italic>. 2004</xref>; <xref ref-type="bibr" rid="bibr35-1756285612443300">Popeney and Alo, 2003</xref>], occipital neuralgia [<xref ref-type="bibr" rid="bibr18-1756285612443300">Johnstone and Sundaraj, 2006</xref>; <xref ref-type="bibr" rid="bibr19-1756285612443300">Kapural <italic>et al</italic>. 2005</xref>; <xref ref-type="bibr" rid="bibr42-1756285612443300">Slavin <italic>et al</italic>. 2006</xref>] and other intractable headache disorders [<xref ref-type="bibr" rid="bibr49-1756285612443300">Weiner and Reed, 1999</xref>].</p>
<p>Also the use of a small unilateral completely implantable miniaturized device known as ‘bion’ has yielded favourable results in patients with hemicrania continua [<xref ref-type="bibr" rid="bibr4-1756285612443300">Burns <italic>et al</italic>. 2008</xref>].</p>
<p>The role of occipital stimulation in CH was first examined by Burns and colleagues. They published a pilot study of 8 patients [<xref ref-type="bibr" rid="bibr3-1756285612443300">Burns <italic>et al</italic>. 2007</xref>] and a follow-up study of 14 patients [<xref ref-type="bibr" rid="bibr5-1756285612443300">Burns <italic>et al</italic>. 2009</xref>] on ONS for CCH. In the pilot study 6 of 8 patients and in the follow-up study 10 of 14 patients experienced a reduction in attack frequency. The reduction of attack frequency was more than 40% in 6 of 8 patients in the pilot study and six of 14 patients in the follow-up study. In a study by Magis and colleagues seven of eight patients had a decrease in attack frequency of more than 40% [<xref ref-type="bibr" rid="bibr26-1756285612443300">Magis <italic>et al</italic>. 2007</xref>]. Mean attack frequency was decreased by 19%, 29% and 80% in the two studies of Burns and colleagues and the study of Magis coworkers, respectively. In the latter study, on average the ONS to baseline attack ratio per month was 0.65 during the whole follow up (mean 15.1 months).</p>
</sec>
<sec id="section5-1756285612443300">
<title>Spinal cord stimulation</title>
<p>Spinal cord stimulation (SCS) has for a long time been successfully employed in a variety of neuropathic pain syndromes as well as in vasogenic pain such as angina pectoris or peripheral vascular disease. There are recent reports on stimulation of the craniocervical junction for several types of head and facial pain [<xref ref-type="bibr" rid="bibr2-1756285612443300">Balzer <italic>et al</italic>. 2011</xref>; <xref ref-type="bibr" rid="bibr47-1756285612443300">Tomycz <italic>et al</italic>. 2011</xref>]. The latter may be regarded as a kind of very high cervical SCS.</p>
<p>Seven years ago we treated a patient with medication refractory cluster headache. We decided to perform a test of cervical SCS electrode as compassionate treatment. The clinical results in this patient in the postoperative course and in the long-term follow up were quite encouraging [<xref ref-type="bibr" rid="bibr50-1756285612443300">Wolter <italic>et al</italic>. 2008</xref>] and we decided to offer this treatment option to other patients with refractory CCH. By now we have implanted eight patients and the clinical results of the first seven patients were published recently [<xref ref-type="bibr" rid="bibr51-1756285612443300">Wolter <italic>et al</italic>. 2011</xref>]. All in all, SCS in our study showed clinical effects comparable to or better than ONS (<xref ref-type="table" rid="table1-1756285612443300">Table 1</xref>). The promising clinical results, however, were shadowed by a high rate of lead breakages and dislocations. These complications, however, were benign and easy to handle.</p>
<table-wrap id="table1-1756285612443300" position="float">
<label>Table 1.</label>
<caption><p>Overview of results from different neurostimulation studies for chronic cluster headache.</p></caption>
<graphic alternate-form-of="table1-1756285612443300" xlink:href="10.1177_1756285612443300-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="left">Modality</th>
<th align="left"><italic>n</italic></th>
<th align="left">Reduction of attack frequency</th>
<th align="left">Reduction of attack strength</th>
<th align="left">Reduction of attack duration</th>
</tr>
</thead>
<tbody>
<tr>
<td><xref ref-type="bibr" rid="bibr3-1756285612443300">Burns <italic>et al</italic>. [2007</xref>]</td>
<td>ONS</td>
<td>8</td>
<td>19%</td>
<td>23%</td>
<td>n.d.</td>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr26-1756285612443300">Magis <italic>et al</italic>. [2007</xref>]</td>
<td>ONS</td>
<td>9</td>
<td>75%</td>
<td>50%</td>
<td>n.d.</td>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr5-1756285612443300">Burns <italic>et al</italic>. [2009</xref>]</td>
<td>ONS</td>
<td>14</td>
<td>29%</td>
<td>6%</td>
<td>n.d.</td>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr48-1756285612443300">Tronnier and Rasche [2010</xref>]</td>
<td>ONS</td>
<td>4</td>
<td>82%</td>
<td>38%</td>
<td>n.d.</td>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr51-1756285612443300">Wolter <italic>et al</italic>. [2011</xref>]</td>
<td>SCS</td>
<td>7</td>
<td>84%</td>
<td>41%</td>
<td>56%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1756285612443300">
<p>n.d., not described; ONS, occipital nerve stimulation; SCS, spinal cord stimulation</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>SCS in contrast to ONS acts immediately. All of our patients felt at least some effect from SCS from the operation day onward. This allows for a test phase, prior to implantation of the impulse generator. Electrodes can also be implanted bilaterally, in the case of side switch of CCH. In two of our patients this was the case: both received a second contralateral electrode, and now they are able to control head pain on both sides separately.</p>
<p>Although being slightly more invasive than ONS, in SCS the risks of the intervention are minimal. In our view it is still too early to decide whether SCS might become a first-line treatment for therapy refractory CCH. However, it can be used as a reserve option in the case of insufficient effects of ONS.</p>
</sec>
<sec id="section6-1756285612443300">
<title>Ganglion sphenopalatinum stimulation</title>
<p>The sphenopalatine (pterygopalatine) ganglion (SPG) receives input from the maxillary branch of the trigeminal nerve, parasympathetic fibres originating from the superior salivatory nucleus in the brainstem and sympathetic fibres form the carotid plexus (via the deep petrosal nerve). In the SPG there is a tight anatomical and physiological relationship of sympathetic, parasympathetic and trigeminal fibres. The SPG plays a pivotal role in driving the parasympathetic features and in sterile meningeal inflammation as substrate for trigeminally mediated head pain, as well as in pain transmission in CH. Consequently the SPG has been targeted in a couple of lesional treatments [<xref ref-type="bibr" rid="bibr11-1756285612443300">Felisati <italic>et al</italic>. 2006</xref>; <xref ref-type="bibr" rid="bibr21-1756285612443300">Lad <italic>et al</italic>. 2007</xref>; <xref ref-type="bibr" rid="bibr37-1756285612443300">Sanders and Zuurmond, 1997</xref>; <xref ref-type="bibr" rid="bibr43-1756285612443300">Solomon and Apfelbaum, 1986</xref>]. Recently a case of long-term neurostimulation of the SPG has been reported with excellent and long-lasting pain relief [<xref ref-type="bibr" rid="bibr16-1756285612443300">Ibarra, 2007</xref>]. Moreover, a new study showed that stimulation of the SPG can be effective as an acute treatment for cluster attacks. In six patients, 18 attacks were treated and a complete resolution of symptoms was seen in 11 attacks, a partial resolution of symptoms in three attacks and minimal or no relief in four attacks [<xref ref-type="bibr" rid="bibr1-1756285612443300">Ansarinia <italic>et al</italic>. 2010</xref>]. Similar results have been reported after SPG stimulation as acute treatment for migraine [<xref ref-type="bibr" rid="bibr46-1756285612443300">Tepper <italic>et al</italic>. 2009</xref>]. SPG stimulation becomes particularly attractive, because it may, in contrast to ONS and SCS, offer the possibility to abort an ongoing attack. Therefore, future studies of stimulation of the SPG are urgently warranted.</p>
</sec>
<sec id="section7-1756285612443300">
<title>Recommendations</title>
<p>Neurostimulation has opened promising perspectives for the treatment of refractory CCH. ONS and SCS seem to have a stronger pain relieving effect than DBS. Therefore, apart from the inherent risks of DBS, this option should not be performed as a first-line treatment for refractory CCH. To the best of the authors’ knowledge, there are no more ongoing trials of DBS for CCH in Germany. Whether SCS should be used as a first-line therapy or as a reserve therapy cannot be decided on the basis of the present data.</p>
<p>SPG stimulation might become an attractive alternative to ONS and SCS but on the basis of the present data it cannot yet be recommended, except in the context of a clinical study.</p>
</sec>
<sec id="section8-1756285612443300">
<title>Future perspectives</title>
<p>Further studies will show whether there is a place for SPG stimulation in the future. Irrespective from the final lead location, in the future new programming parameters (i.e. burst stimulation [<xref ref-type="bibr" rid="bibr6-1756285612443300">De Ridder <italic>et al</italic>. 2010</xref>] ) or high-frequency stimulation may deliver improved pain relief in our patients.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure"><p>T. Wolter has received a single travel grant from Boston Scientific in 2010.</p></fn>
<fn fn-type="conflict"><p>H. Kaube was member of the advisory board of MSD. He received honoraria for lectures from Boehringer, Pfizer, Medtronic, Boston Scientific and ANS St Jude.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ansarinia</surname><given-names>M.</given-names></name>
<name><surname>Rezai</surname><given-names>A.</given-names></name>
<name><surname>Tepper</surname><given-names>S.J.</given-names></name>
<name><surname>Steiner</surname><given-names>C.P.</given-names></name>
<name><surname>Stump</surname><given-names>J.</given-names></name>
<name><surname>Stanton-Hicks</surname><given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches</article-title>. <source>Headache</source> <volume>50</volume>: <fpage>1164</fpage>–<lpage>1174</lpage>.</citation>
</ref>
<ref id="bibr2-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Balzer</surname><given-names>J.R.</given-names></name>
<name><surname>Tomycz</surname><given-names>N.D.</given-names></name>
<name><surname>Crammond</surname><given-names>D.J.</given-names></name>
<name><surname>Habeych</surname><given-names>M.</given-names></name>
<name><surname>Thirumala</surname><given-names>P.D.</given-names></name>
<name><surname>Urgo</surname><given-names>L.</given-names></name>
<etal/>
</person-group>. (<year>2011</year>) <article-title>Localization of cervical and cervicomedullary stimulation leads for pain treatment using median nerve somatosensory evoked potential collision testing</article-title>. <source>J Neurosurg</source> <volume>114</volume>: <fpage>200</fpage>–<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr3-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burns</surname><given-names>B.</given-names></name>
<name><surname>Watkins</surname><given-names>L.</given-names></name>
<name><surname>Goadsby</surname><given-names>P.J.</given-names></name>
</person-group> (<year>2007</year>) <article-title>Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients</article-title>. <source>Lancet</source> <volume>369</volume>: <fpage>1099</fpage>–<lpage>1106</lpage>.</citation>
</ref>
<ref id="bibr4-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burns</surname><given-names>B.</given-names></name>
<name><surname>Watkins</surname><given-names>L.</given-names></name>
<name><surname>Goadsby</surname><given-names>P.J.</given-names></name>
</person-group> (<year>2008</year>) <article-title>Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study</article-title>. <source>Lancet Neurol</source> <volume>7</volume>: <fpage>1001</fpage>–<lpage>1012</lpage>.</citation>
</ref>
<ref id="bibr5-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burns</surname><given-names>B.</given-names></name>
<name><surname>Watkins</surname><given-names>L.</given-names></name>
<name><surname>Goadsby</surname><given-names>P.J.</given-names></name>
</person-group> (<year>2009</year>) <article-title>Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients</article-title>. <source>Neurology</source> <volume>72</volume>: <fpage>341</fpage>–<lpage>345</lpage>.</citation>
</ref>
<ref id="bibr6-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Ridder</surname><given-names>D.</given-names></name>
<name><surname>Vanneste</surname><given-names>S.</given-names></name>
<name><surname>Plazier</surname><given-names>M.</given-names></name>
<name><surname>van der Loo</surname><given-names>E.</given-names></name>
<name><surname>Menovsky</surname><given-names>T.</given-names></name>
</person-group> (<year>2010</year>) <article-title>Burst spinal cord stimulation: toward paresthesia-free pain suppression</article-title>. <source>Neurosurgery</source> <volume>66</volume>: <fpage>986</fpage>–<lpage>990</lpage>.</citation>
</ref>
<ref id="bibr7-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dodick</surname><given-names>D.W.</given-names></name>
<name><surname>Capobianco</surname><given-names>D.J.</given-names></name>
</person-group> (<year>2001</year>) <article-title>Treatment and management of cluster headache</article-title>. <source>Curr Pain Headache Rep</source> <volume>5</volume>: <fpage>83</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr8-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Donnet</surname><given-names>A.</given-names></name>
<name><surname>Tamura</surname><given-names>M.</given-names></name>
<name><surname>Valade</surname><given-names>D.</given-names></name>
<name><surname>Regis</surname><given-names>J.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Trigeminal nerve radiosurgical treatment in intractable chronic cluster headache: unexpected high toxicity</article-title>. <source>Neurosurgery</source> <volume>59</volume>: <fpage>1252</fpage>–<lpage>1257</lpage>; <comment>discussion 1257</comment>.</citation>
</ref>
<ref id="bibr9-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Donnet</surname><given-names>A.</given-names></name>
<name><surname>Valade</surname><given-names>D.</given-names></name>
<name><surname>Regis</surname><given-names>J.</given-names></name>
</person-group> (<year>2005</year>) <article-title>Gamma knife treatment for refractory cluster headache: prospective open trial</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <volume>76</volume>: <fpage>218</fpage>–<lpage>221</lpage>.</citation>
</ref>
<ref id="bibr10-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ekbom</surname><given-names>K.</given-names></name>
<name><surname>Lindgren</surname><given-names>L.</given-names></name>
<name><surname>Nilsson</surname><given-names>B.Y.</given-names></name>
<name><surname>Hardebo</surname><given-names>J.E.</given-names></name>
<name><surname>Waldenlind</surname><given-names>E.</given-names></name>
</person-group> (<year>1987</year>) <article-title>Retro-Gasserian glycerol injection in the treatment of chronic cluster headache</article-title>. <source>Cephalalgia</source> <volume>7</volume>: <fpage>21</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr11-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Felisati</surname><given-names>G.</given-names></name>
<name><surname>Arnone</surname><given-names>F.</given-names></name>
<name><surname>Lozza</surname><given-names>P.</given-names></name>
<name><surname>Leone</surname><given-names>M.</given-names></name>
<name><surname>Curone</surname><given-names>M.</given-names></name>
<name><surname>Bussone</surname><given-names>G.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Sphenopalatine endoscopic ganglion block: a revision of a traditional technique for cluster headache</article-title>. <source>Laryngoscope</source> <volume>116</volume>: <fpage>1447</fpage>–<lpage>1450</lpage>.</citation>
</ref>
<ref id="bibr12-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fontaine</surname><given-names>D.</given-names></name>
<name><surname>Lazorthes</surname><given-names>Y.</given-names></name>
<name><surname>Mertens</surname><given-names>P.</given-names></name>
<name><surname>Blond</surname><given-names>S.</given-names></name>
<name><surname>Geraud</surname><given-names>G.</given-names></name>
<name><surname>Fabre</surname><given-names>N.</given-names></name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension</article-title>. <source>J Headache Pain</source> <volume>11</volume>: <fpage>23</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr13-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Franzini</surname><given-names>A.</given-names></name>
<name><surname>Ferroli</surname><given-names>P.</given-names></name>
<name><surname>Leone</surname><given-names>M.</given-names></name>
<name><surname>Broggi</surname><given-names>G.</given-names></name>
</person-group> (<year>2003</year>) <article-title>Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series</article-title>. <source>Neurosurgery</source> <volume>52</volume>: <fpage>1095</fpage>-<lpage>1099</lpage>; <comment>discussion 1099–1101</comment>.</citation>
</ref>
<ref id="bibr14-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goadsby</surname><given-names>P.J.</given-names></name>
<name><surname>Schoenen</surname><given-names>J.</given-names></name>
<name><surname>Ferrari</surname><given-names>M.D.</given-names></name>
<name><surname>Silberstein</surname><given-names>S.D.</given-names></name>
<name><surname>Dodick</surname><given-names>D.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Towards a definition of intractable headache for use in clinical practice and trials</article-title>. <source>Cephalalgia</source> <volume>26</volume>: <fpage>1168</fpage>–<lpage>1170</lpage>.</citation>
</ref>
<ref id="bibr15-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Green</surname><given-names>M.W.</given-names></name>
</person-group> (<year>2003</year>) <article-title>Long-term follow-up of chronic cluster headache treated surgically with trigeminal tractotomy</article-title>. <source>Headache</source> <volume>43</volume>: <fpage>479</fpage>–<lpage>481</lpage>.</citation>
</ref>
<ref id="bibr16-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ibarra</surname><given-names>E.</given-names></name>
</person-group> (<year>2007</year>) <article-title>Neuromodulación del Ganglio Esfenopalatino para Aliviar los Síntomas de la Cefalea en Racimos. Reporte de un Caso</article-title>. <source>Boletín El Dolor</source> <volume>46</volume>(<issue>16</issue>): <fpage>12</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr17-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jarrar</surname><given-names>R.G.</given-names></name>
<name><surname>Black</surname><given-names>D.F.</given-names></name>
<name><surname>Dodick</surname><given-names>D.W.</given-names></name>
<name><surname>Davis</surname><given-names>D.H.</given-names></name>
</person-group> (<year>2003</year>) <article-title>Outcome of trigeminal nerve section in the treatment of chronic cluster headache</article-title>. <source>Neurology</source> <volume>60</volume>: <fpage>1360</fpage>–<lpage>1362</lpage>.</citation>
</ref>
<ref id="bibr18-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Johnstone</surname><given-names>C.</given-names></name>
<name><surname>Sundaraj</surname><given-names>R.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Occipital nerve stimulation for the treatment of occipital neuralgia—eight case studies</article-title>. <source>Neuromodulation</source> <volume>9</volume>: <fpage>41</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr19-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kapural</surname><given-names>L.</given-names></name>
<name><surname>Mekhail</surname><given-names>N.</given-names></name>
<name><surname>Hayek</surname><given-names>S.M.</given-names></name>
<name><surname>Stanton-Hicks</surname><given-names>M.</given-names></name>
<name><surname>Malak</surname><given-names>O.</given-names></name>
</person-group> (<year>2005</year>) <article-title>Occipital nerve electrical stimulation via the midline approach and subcutaneous surgical leads for treatment of severe occipital neuralgia: a pilot study</article-title>. <source>Anesth Analg</source> <volume>101</volume>: <fpage>171</fpage>–<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr20-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kirkpatrick</surname><given-names>P.J.</given-names></name>
<name><surname>O’Brien</surname><given-names>M.D.</given-names></name>
<name><surname>MacCabe</surname><given-names>J.J.</given-names></name>
</person-group> (<year>1993</year>) <article-title>Trigeminal nerve section for chronic migrainous neuralgia</article-title>. <source>Br J Neurosurg</source> <volume>7</volume>: <fpage>483</fpage>–<lpage>490</lpage>.</citation>
</ref>
<ref id="bibr21-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lad</surname><given-names>S.P.</given-names></name>
<name><surname>Lipani</surname><given-names>J.D.</given-names></name>
<name><surname>Gibbs</surname><given-names>I.C.</given-names></name>
<name><surname>Chang</surname><given-names>S.D.</given-names></name>
<name><surname>Adler</surname><given-names>J.R.</given-names><suffix>Jr</suffix></name>
<name><surname>Henderson</surname><given-names>J.M.</given-names></name>
</person-group> (<year>2007</year>) <article-title>Cyberknife targeting the pterygopalatine ganglion for the treatment of chronic cluster headaches</article-title>. <source>Neurosurgery</source> <volume>60</volume>: <fpage>E580</fpage>-<lpage>E581</lpage>; <comment>discussion E581</comment>.</citation>
</ref>
<ref id="bibr22-1756285612443300">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Lance</surname><given-names>J.W.</given-names></name>
<name><surname>Goadsby</surname><given-names>P.J.</given-names></name>
</person-group> (<year>2005</year>) <source>Mechanism and Management of Headache</source>, <edition>7th edn.</edition> <publisher-loc>New York</publisher-loc>: <publisher-name>Elsevier</publisher-name>.</citation>
</ref>
<ref id="bibr23-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leone</surname><given-names>M.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Deep brain stimulation in headache</article-title>. <source>Lancet Neurol</source> <volume>5</volume>: <fpage>873</fpage>–<lpage>877</lpage>.</citation>
</ref>
<ref id="bibr24-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leone</surname><given-names>M.</given-names></name>
<name><surname>May</surname><given-names>A.</given-names></name>
<name><surname>Franzini</surname><given-names>A.</given-names></name>
<name><surname>Broggi</surname><given-names>G.</given-names></name>
<name><surname>Dodick</surname><given-names>D.</given-names></name>
<name><surname>Rapoport</surname><given-names>A.</given-names></name>
<etal/>
</person-group>. (<year>2004</year>) <article-title>Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection</article-title>. <source>Cephalalgia</source> <volume>24</volume>: <fpage>934</fpage>–<lpage>937</lpage>.</citation>
</ref>
<ref id="bibr25-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leone</surname><given-names>M.</given-names></name>
<name><surname>Proietti Cecchini</surname><given-names>A.</given-names></name>
<name><surname>Franzini</surname><given-names>A.</given-names></name>
<name><surname>Broggi</surname><given-names>G.</given-names></name>
<name><surname>Cortelli</surname><given-names>P.</given-names></name>
<name><surname>Montagna</surname><given-names>P.</given-names></name>
<etal/>
</person-group>. (<year>2008</year>) <article-title>Lessons from 8 years’ experience of hypothalamic stimulation in cluster headache</article-title>. <source>Cephalalgia</source> <volume>28</volume>: <fpage>787</fpage>–<lpage>797</lpage>; <comment>discussion 798</comment>.</citation>
</ref>
<ref id="bibr26-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Magis</surname><given-names>D.</given-names></name>
<name><surname>Allena</surname><given-names>M.</given-names></name>
<name><surname>Bolla</surname><given-names>M.</given-names></name>
<name><surname>De Pasqua</surname><given-names>V.</given-names></name>
<name><surname>Remacle</surname><given-names>J.M.</given-names></name>
<name><surname>Schoenen</surname><given-names>J.</given-names></name>
</person-group> (<year>2007</year>) <article-title>Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study</article-title>. <source>Lancet Neurol</source> <volume>6</volume>: <fpage>314</fpage>–<lpage>321</lpage>.</citation>
</ref>
<ref id="bibr27-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matharu</surname><given-names>M.S.</given-names></name>
<name><surname>Bartsch</surname><given-names>T.</given-names></name>
<name><surname>Ward</surname><given-names>N.</given-names></name>
<name><surname>Frackowiak</surname><given-names>R.S.</given-names></name>
<name><surname>Weiner</surname><given-names>R.</given-names></name>
<name><surname>Goadsby</surname><given-names>P.J.</given-names></name>
</person-group> (<year>2004</year>) <article-title>Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study</article-title>. <source>Brain</source> <volume>127</volume>: <fpage>220</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr28-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matharu</surname><given-names>M.S.</given-names></name>
<name><surname>Zrinzo</surname><given-names>L.</given-names></name>
</person-group> (<year>2010</year>) <article-title>Deep brain stimulation in cluster headache: hypothalamus or midbrain tegmentum?</article-title> <source>Curr Pain Headache Rep</source> <volume>14</volume>: <fpage>151</fpage>–<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr29-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matharu</surname><given-names>M.S.</given-names></name>
<name><surname>Zrinzo</surname><given-names>L.</given-names></name>
</person-group> (<year>2011</year>) <article-title>Deep brain stimulation in cluster headache</article-title>. <source>Expert Rev Neurother</source> <volume>11</volume>: <fpage>473</fpage>–<lpage>475</lpage>.</citation>
</ref>
<ref id="bibr30-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mathew</surname><given-names>N.T.</given-names></name>
<name><surname>Hurt</surname><given-names>W.</given-names></name>
</person-group> (<year>1988</year>) <article-title>Percutaneous radiofrequency trigeminal gangliorhizolysis in intractable cluster headache</article-title>. <source>Headache</source> <volume>28</volume>: <fpage>328</fpage>–<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr31-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>May</surname><given-names>A.</given-names></name>
<name><surname>Bahra</surname><given-names>A.</given-names></name>
<name><surname>Buchel</surname><given-names>C.</given-names></name>
<name><surname>Frackowiak</surname><given-names>R.S.</given-names></name>
<name><surname>Goadsby</surname><given-names>P.J.</given-names></name>
</person-group> (<year>1998</year>) <article-title>Hypothalamic activation in cluster headache attacks</article-title>. <source>Lancet</source> <volume>352</volume>: <fpage>275</fpage>–<lpage>278</lpage>.</citation>
</ref>
<ref id="bibr32-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McClelland</surname><given-names>S.</given-names><suffix>III</suffix></name>
<name><surname>Barnett</surname><given-names>G.H.</given-names></name>
<name><surname>Neyman</surname><given-names>G.</given-names></name>
<name><surname>Suh</surname><given-names>J.H.</given-names></name>
</person-group> (<year>2007</year>) <article-title>Repeat trigeminal nerve radiosurgery for refractory cluster headache fails to provide long-term pain relief</article-title>. <source>Headache</source> <volume>47</volume>: <fpage>298</fpage>–<lpage>300</lpage>.</citation>
</ref>
<ref id="bibr33-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McClelland</surname><given-names>S.</given-names><suffix>III</suffix></name>
<name><surname>Tendulkar</surname><given-names>R.D.</given-names></name>
<name><surname>Barnett</surname><given-names>G.H.</given-names></name>
<name><surname>Neyman</surname><given-names>G.</given-names></name>
<name><surname>Suh</surname><given-names>J.H.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Long-term results of radiosurgery for refractory cluster headache</article-title>. <source>Neurosurgery</source> <volume>59</volume>: <fpage>1258</fpage>-<lpage>1262</lpage>; <comment>discussion 1262–1253</comment>.</citation>
</ref>
<ref id="bibr34-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morgenlander</surname><given-names>J.C.</given-names></name>
<name><surname>Wilkins</surname><given-names>R.H.</given-names></name>
</person-group> (<year>1990</year>) <article-title>Surgical treatment of cluster headache</article-title>. <source>J Neurosurg</source> <volume>72</volume>: <fpage>866</fpage>–<lpage>871</lpage>.</citation>
</ref>
<ref id="bibr35-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Popeney</surname><given-names>C.A.</given-names></name>
<name><surname>Alo</surname><given-names>K.M.</given-names></name>
</person-group> (<year>2003</year>) <article-title>Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine</article-title>. <source>Headache</source> <volume>43</volume>: <fpage>369</fpage>–<lpage>375</lpage>.</citation>
</ref>
<ref id="bibr36-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rowed</surname><given-names>D.W.</given-names></name>
</person-group> (<year>1990</year>) <article-title>Chronic cluster headache managed by nervus intermedius section</article-title>. <source>Headache</source> <volume>30</volume>: <fpage>401</fpage>–<lpage>406</lpage>.</citation>
</ref>
<ref id="bibr37-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sanders</surname><given-names>M.</given-names></name>
<name><surname>Zuurmond</surname><given-names>W.W.</given-names></name>
</person-group> (<year>1997</year>) <article-title>Efficacy of sphenopalatine ganglion blockade in 66 patients suffering from cluster headache: a 12- to 70-month follow-up evaluation</article-title>. <source>J Neurosurg</source> <volume>87</volume>: <fpage>876</fpage>–<lpage>880</lpage>.</citation>
</ref>
<ref id="bibr38-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sano</surname><given-names>K.</given-names></name>
<name><surname>Mayanagi</surname><given-names>Y.</given-names></name>
<name><surname>Sekino</surname><given-names>H.</given-names></name>
<name><surname>Ogashiwa</surname><given-names>M.</given-names></name>
<name><surname>Ishijima</surname><given-names>B.</given-names></name>
</person-group> (<year>1970</year>) <article-title>Results of stimulation and destruction of the posterior hypothalamus in man</article-title>. <source>J Neurosurg</source> <volume>33</volume>: <fpage>689</fpage>–<lpage>707</lpage>.</citation>
</ref>
<ref id="bibr39-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schoenen</surname><given-names>J.</given-names></name>
<name><surname>Di Clemente</surname><given-names>L.</given-names></name>
<name><surname>Vandenheede</surname><given-names>M.</given-names></name>
<name><surname>Fumal</surname><given-names>A.</given-names></name>
<name><surname>De Pasqua</surname><given-names>V.</given-names></name>
<name><surname>Mouchamps</surname><given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2005</year>) <article-title>Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action</article-title>. <source>Brain</source> <volume>128</volume>: <fpage>940</fpage>–<lpage>947</lpage>.</citation>
</ref>
<ref id="bibr40-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Silberstein</surname><given-names>S.D.</given-names></name>
<name><surname>Olesen</surname><given-names>J.</given-names></name>
<name><surname>Bousser</surname><given-names>M.G.</given-names></name>
<name><surname>Diener</surname><given-names>H.C.</given-names></name>
<name><surname>Dodick</surname><given-names>D.</given-names></name>
<name><surname>First</surname><given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2005</year>) <article-title>The International Classification of Headache Disorders, 2nd Edition (ICHD-II) - revision of criteria for 8.2 Medication-overuse headache</article-title>. <source>Cephalalgia</source> <volume>25</volume>: <fpage>460</fpage>–<lpage>465</lpage>.</citation>
</ref>
<ref id="bibr41-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sjaastad</surname><given-names>O.</given-names></name>
<name><surname>Bakketeig</surname><given-names>L.S.</given-names></name>
</person-group> (<year>2003</year>) <article-title>Prolonged benign exertional headache. The Vaga Study of headache epidemiology</article-title>. <source>Headache</source> <volume>43</volume>: <fpage>611</fpage>–<lpage>615</lpage>.</citation>
</ref>
<ref id="bibr42-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Slavin</surname><given-names>K.V.</given-names></name>
<name><surname>Nersesyan</surname><given-names>H.</given-names></name>
<name><surname>Wess</surname><given-names>C.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Peripheral neurostimulation for treatment of intractable occipital neuralgia</article-title>. <source>Neurosurgery</source> <volume>58</volume>: <fpage>112</fpage>–<lpage>119</lpage>; <comment>discussion 112–119</comment>.</citation>
</ref>
<ref id="bibr43-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Solomon</surname><given-names>S.</given-names></name>
<name><surname>Apfelbaum</surname><given-names>R.I.</given-names></name>
</person-group> (<year>1986</year>) <article-title>Surgical decompression of the facial nerve in the treatment of chronic cluster headache</article-title>. <source>Arch Neurol</source> <volume>43</volume>: <fpage>479</fpage>–<lpage>482</lpage>.</citation>
</ref>
<ref id="bibr44-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sprenger</surname><given-names>T.</given-names></name>
<name><surname>Boecker</surname><given-names>H.</given-names></name>
<name><surname>Tolle</surname><given-names>T.R.</given-names></name>
<name><surname>Bussone</surname><given-names>G.</given-names></name>
<name><surname>May</surname><given-names>A.</given-names></name>
<name><surname>Leone</surname><given-names>M.</given-names></name>
</person-group> (<year>2004</year>) <article-title>Specific hypothalamic activation during a spontaneous cluster headache attack</article-title>. <source>Neurology</source> <volume>62</volume>: <fpage>516</fpage>–<lpage>517</lpage>.</citation>
</ref>
<ref id="bibr45-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sweet</surname><given-names>W.H.</given-names></name>
</person-group> (<year>1988</year>) <article-title>Surgical treatment of chronic cluster headache</article-title>. <source>Headache</source> <volume>28</volume>: <fpage>669</fpage>–<lpage>670</lpage>.</citation>
</ref>
<ref id="bibr46-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tepper</surname><given-names>S.J.</given-names></name>
<name><surname>Rezai</surname><given-names>A.</given-names></name>
<name><surname>Narouze</surname><given-names>S.</given-names></name>
<name><surname>Steiner</surname><given-names>C.</given-names></name>
<name><surname>Mohajer</surname><given-names>P.</given-names></name>
<name><surname>Ansarinia</surname><given-names>M.</given-names></name>
</person-group> (<year>2009</year>) <article-title>Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation</article-title>. <source>Headache</source> <volume>49</volume>: <fpage>983</fpage>–<lpage>989</lpage>.</citation>
</ref>
<ref id="bibr47-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tomycz</surname><given-names>N.D.</given-names></name>
<name><surname>Deibert</surname><given-names>C.P.</given-names></name>
<name><surname>Moossy</surname><given-names>J.J.</given-names></name>
</person-group> (<year>2011</year>) <article-title>Cervicomedullary junction spinal cord stimulation for head and facial pain</article-title>. <source>Headache</source> <volume>51</volume>: <fpage>418</fpage>–<lpage>425</lpage>.</citation>
</ref>
<ref id="bibr48-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tronnier</surname><given-names>V.</given-names></name>
<name><surname>Rasche</surname><given-names>D.</given-names></name>
</person-group> (<year>2010</year>) <article-title>Subcutaneous peripheral stimulation of the greater occipital nerve for the treatment of chronic headache syndromes</article-title>. <source>Schmerz</source> <volume>24</volume>: <fpage>441</fpage>-<lpage>448</lpage>.</citation>
</ref>
<ref id="bibr49-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weiner</surname><given-names>R.L.</given-names></name>
<name><surname>Reed</surname><given-names>K.L.</given-names></name>
</person-group> (<year>1999</year>) <article-title>Peripheral neurostimulation for control of intractable occipital neuralgia</article-title>. <source>Neuromodulation</source> <volume>2</volume>: <fpage>217</fpage>–<lpage>221</lpage>.</citation>
</ref>
<ref id="bibr50-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wolter</surname><given-names>T.</given-names></name>
<name><surname>Kaube</surname><given-names>H.</given-names></name>
<name><surname>Mohadjer</surname><given-names>M.</given-names></name>
</person-group> (<year>2008</year>) <article-title>High cervical epidural neurostimulation for cluster headache: case report and review of the literature</article-title>. <source>Cephalalgia</source> <volume>28</volume>: <fpage>1091</fpage>–<lpage>1094</lpage>.</citation>
</ref>
<ref id="bibr51-1756285612443300">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wolter</surname><given-names>T.</given-names></name>
<name><surname>Kiemen</surname><given-names>A.</given-names></name>
<name><surname>Kaube</surname><given-names>H.</given-names></name>
</person-group> (<year>2011</year>) <article-title>High cervical spinal cord stimulation for chronic cluster headache</article-title>. <source>Cephalalgia</source> <volume>31</volume>: <fpage>1170</fpage>–<lpage>1180</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>